Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models. Journal of Kidney Cancer, [S. l.], v. 12, n. 3, p. 58–65, 2025. DOI: 10.15586/jkcvhl.v12i3.427. Disponível em: https://jkcvhl.com/index.php/jkcvhl/article/view/427. Acesso em: 12 nov. 2025.